Eolving attitudes to Alzheimer's disease among the general public and caregivers in Europe: Findings from the IMPACT survey

This publication has 14 references indexed in Scilit:

• Assessing attitudes and behaviours surrounding Alzheimer's disease in Europe: Key findings of the important perspectives on Alzheimer's care and treatment (IMPACT) survey
  The Journal of nutrition, health and aging, 2010
• Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence
  Dementia and Geriatric Cognitive Disorders, 2009
• Diagnosis of Dementia in Primary Care: A Representative Survey of Family Physicians and Neuropsychiatrists in Germany
  Dementia and Geriatric Cognitive Disorders, 2007
• The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease
  Neurology, 2004
• Diagnosing cognitive impairment and dementia in primary health care - a more active approach is needed
  Age and Ageing, 2003
• A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease
  Neurology, 2001
• A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients
  Neurology, 2001
• A 5-month, randomized, placebo-controlled trial of galantamine in AD
  Neurology, 2000
• Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial Commentary: Another piece of the Alzheimer's jigsaw
  BMJ, 1999
• A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
  Neurology, 1998